BEAM Stock Analysis: Buy, Sell, or Hold?
BEAM - Beam Therapeutics Inc. Common Stock
$24.37
0.15 (0.62%)
▲
5d:
+3.18%
30d:
-11.19%
90d:
-12.09%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
BEAM is down 6.3% this week, but smart money is accumulating calls. Top strike: $30 2026-05-15 with 298 OI. Call ratio: 64% View Scanner →
Strength: 4.6/10
Get Alerted When BEAM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BEAM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BEAM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BEAM is currently trading at $24.37, which is considered slightly low relative to its 30-day fair value range of $23.67 to $28.23.
Technical Outlook: Technically, BEAM is showing sideways momentum. Immediate support is located at $21.63, while resistance sits at $25.82.
Market Sentiment: BEAM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $50.53 (+108.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BEAM is showing sideways momentum. Immediate support is located at $21.63, while resistance sits at $25.82.
Market Sentiment: BEAM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $50.53 (+108.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$23.67 -
$28.23
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding BEAM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 108.6% below Wall St target ($50.53)
Fair Price Analysis
30-Day Fair Range
$23.67 -
$28.23
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$21.63
Resistance Level
$25.82
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.56
Wall Street Target
$50.53
(+108.6%)
Revenue Growth (YoY)
279.5%
Profit Margin
-57.2%
Share & Embed Analysis
Last updated: April 02, 2026 12:43 PM ET
Data refreshes hourly during market hours. Next update: 1:43 PM
Data refreshes hourly during market hours. Next update: 1:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BEAM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Christine Bellon
SELL
1371 shares
2026-01-22
Christine Bellon
SELL
18629 shares
2026-01-15
Fmr Llc
SELL
459 shares
2025-10-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 57 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$100 | 57 HOLD |
Advanced BEAM Option Strategies
Professional options setups generated by AI based on today's BEAM price and gamma walls.
